title: Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
authors.forename: Ashraf S
authors.initials: AS
authors.lastname: Habib
authors.forename: Tong J
authors.initials: TJ
authors.lastname: Gan
mesh_terms: D000932:Antiemetics / Q000009:adverse effects*; D003257:Consumer Product Safety; D004305:Dose-Response Relationship, Drug; D004329:Droperidol / Q000009:adverse effects*; D017277:Drug Approval; D004348:Drug Labeling; D004363:Drug Utilization; D019317:Evidence-Based Medicine; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced / Q000503:physiopathology; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D016171:Torsades de Pointes / Q000139:chemically induced / Q000503:physiopathology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000932:Antiemetics; D004329:Droperidol